You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Renal cancer

Nivolumab for previously treated advanced renal cell carcinoma

  • Technology appraisal guidance
  • Reference number: TA417
  • Published:  23 November 2016
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Expected publication
  2. Final appraisal determination
  3. Notes
  4. Draft guidance: 1
  5. Invitation to participate

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 234 KB)

    Published:
    21 December 2016

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 160 KB)

    Published:
    21 October 2016
  • Committee papers (PDF 1.4 MB)

    Published:
    21 October 2016
  • Committee papers (PDF 505 KB)

    Published:
    21 October 2016

Notes

  • Note

Draft guidance: 1

  • Draft guidance: 1

  • Appraisal consultation document (PDF 157 KB)

    Published:
    05 July 2016
  • Committee papers (PDF 10.67 MB)

    Published:
    27 October 2016
  • Committee papers (PDF 680 KB)

    Published:
    27 October 2016

Invitation to participate

  • Final scope (PDF 86 KB)

    Published:
    16 May 2016
  • Final matrix (PDF 92 KB)

    Published:
    16 May 2016
  • Equality impact assessment (Scoping) (PDF 73 KB)

    Published:
    16 May 2016
Back to top